Key messages

  • Constipation in palliative care is commonly defined as fewer than three bowel movements per week, with symptoms including hard stools, straining, and a sensation of incomplete evacuation, often exacerbated by opioid use.
  • Opioid-induced constipation (OIC) is a frequent side effect in palliative care
  • Assessing constipation in palliative care requires a comprehensive approach that combines both objective and subjective evaluations.
  • Non-pharmacological treatments, including dietary modifications and hydration, can complement pharmacological strategies but require careful application based on individual patient needs.
  • Pharmacological management of constipation often involves the use of stimulant, osmotic, and bulk-forming laxatives.

Related Evidence

Suggest a tool

Have a favourite clinical tool not listed here? Contact us.

Definition and prevalence

Constipation is described as a decrease in bowel movement frequency, typically defined as fewer than three bowel movements per week, accompanied by symptoms such as hard stools, straining, and a sensation of incomplete evacuation. [1] In the palliative care context, reduced physical activity and medication side effects, particularly from opioids, exacerbate the condition.

Opioid-induced constipation (OIC) is a common side effect of opioid medications, which are frequently used in palliative care for pain management. OIC occurs when opioids bind to mu-opioid receptors in the gastrointestinal (GI) tract, leading to slowed peristalsis, reduced fluid secretion into the intestines, and increased water absorption from the bowel. [2-4] This results in harder stools, less frequent bowel movements, and symptoms such as straining and a feeling of incomplete evacuation. OIC can significantly affect a patient’s quality of life, causing discomfort and distress, which can be particularly challenging in palliative care where maintaining comfort is a priority. OIC affects up to 90% of palliative care patients on opioid therapy. [4] The high rate of OIC underscores the need for proactive management strategies, as untreated constipation can severely impact quality of life.


Assessment

Assessing constipation in palliative care requires a comprehensive approach that combines both objective and subjective evaluations. Objective measures often include bowel movement frequency, stool consistency, and the degree of straining during defecation. Tools such as the Bristol Stool Chart are commonly used to categorise stool types and guide treatment decisions. [3] However, relying solely on these physical indicators may not fully capture the patient’s overall experience, especially in palliative care, where factors like psychological well-being and overall quality of life are also important. [5]

Subjective assessments are valuable for capturing the broader impacts of constipation on patients. Patients may report symptoms such as discomfort, bloating, and emotional distress, which can influence their quality of life. [6] These subjective experiences, however, may be underreported due to factors such as embarrassment or cultural sensitivities, which underscores the need for sensitive communication between healthcare providers and patients. [1]

In cases of severe constipation, faecal impaction can lead to overflow diarrhoea, where liquid stool bypasses the impacted faeces. This complication can sometimes be misinterpreted as diarrhoea but is a sign of significant constipation. [1] Overflow should be suspected in patients presenting with paradoxical loose stools alongside infrequent bowel movements, prolonged periods without defecation, or discomfort. [1,5]

Regular reassessment is recommended because constipation in palliative care patients can vary due to changes in medication, diet, and overall health status. Early identification and routine assessment of OIC can facilitate timely interventions, potentially improving the patient's comfort and quality of life. [2,3]


Non-pharmacological treatment

Non-pharmacological approaches are frequently recommended in palliative care to manage constipation, providing an alternative or complementary strategy to pharmacological treatments. These approaches often include dietary modifications, hydration, physical activity, and alternative therapies, though their application can be inconsistent across care settings. [3,6]

Dietary adjustments, particularly increasing dietary fibre intake, are commonly advised to improve bowel regularity. Fibre can be introduced through food or supplements, and while it is generally effective in promoting bowel movements, its success may depend on the patient’s overall health and mobility. [6] Adequate hydration is another key component, as sufficient fluid intake is essential for softening stools and facilitating regular bowel movements. However, these recommendations must be tailored to the individual, especially in palliative care patients who may be frail or have other medical complications that impact their ability to tolerate increased fibre or fluid intake. [3]

Physical activity, where possible, is also recommended to stimulate bowel function. Even minimal movement, such as gentle exercises or walking, can help reduce the risk of constipation. [3] However, in palliative care settings, many patients have limited mobility, which can reduce the feasibility and effectiveness of physical activity as a treatment option. For these patients, healthcare providers may need to consider other methods to encourage bowel regularity, acknowledging the limitations imposed by the patient’s condition. [6]

Alternative therapies, including massage, reflexology, and acupuncture, have been explored as non-pharmacological interventions for constipation. While the evidence supporting these therapies varies, they are considered beneficial in some cases, particularly when integrated into a comprehensive care plan. [7] For example, abdominal massage has been shown to improve bowel movements and reduce discomfort in certain patients, though its use depends on the patient’s comfort and overall condition. [6,7]


Pharmacological treatment

Pharmaceutical treatments are fundamental in managing constipation in palliative care, particularly due to the prevalence of OIC. The primary pharmaceutical interventions include various types of laxatives, such as stimulant, osmotic, and bulk-forming agents. Laxatives are central to pharmaceutical management, with stimulant laxatives like senna and bisacodyl being commonly used. These agents increase intestinal motility, promoting bowel movements, and are often chosen for their ability to provide rapid relief. [3,8] However, stimulant laxatives can sometimes cause side effects such as abdominal cramps and diarrhoea, making it essential to monitor patients and adjust dosages as needed to balance efficacy and tolerability. [6]

Osmotic laxatives, such as lactulose and polyethylene glycol, are frequently used to soften stools by drawing water into the bowel, which facilitates easier defecation. [4] These laxatives are valued for their effectiveness, although they typically act more slowly than stimulant laxatives, which may influence their use depending on the urgency of symptom relief. [3,6] The decision between osmotic and stimulant laxatives often depends on the patient’s symptoms, urgency of treatment, and overall health status. [6]

Bulk-forming laxatives, such as psyllium, are less commonly utilised in palliative care due to the requirement for adequate hydration and the potential for increased bloating and discomfort. [3] These agents work by absorbing water in the intestines, increasing stool bulk and promoting peristalsis, but their effectiveness may be limited in palliative care patients, especially those with reduced fluid intake or mobility. [6]

Stool softeners, like docusate sodium, are sometimes prescribed to increase the water content of stools, making them easier to pass. [4] However, the effectiveness of stool softeners alone is debated, and they are often used in combination with other laxatives to enhance their overall efficacy. [3]

Pharmaceutical management of constipation in palliative care often requires a personalised approach, combining different classes of medications based on the patient’s symptoms, response to treatment, and overall health status. [6] Regular reassessment is crucial to ensure that the treatment remains effective and to adjust the regimen as the patient’s condition evolves. [2,3]

Equity and access

Patients from culturally and linguistically diverse (CALD) backgrounds may encounter barriers in accessing appropriate care for constipation. Language differences can complicate communication, potentially leading to underreporting of symptoms or misunderstandings about treatment options. [5] In some cultures, discussing bowel habits is considered private, which might affect a patient’s willingness to seek help or discuss their symptoms openly with healthcare providers. [4] This context highlights the value of culturally sensitive approaches in healthcare, including the use of interpreters and culturally appropriate educational materials, to help ensure that patients receive care that aligns with their cultural beliefs while effectively managing their symptoms. [9]

Economic factors also play a role in access to constipation management. Patients with limited financial resources may find it challenging to afford the full range of available treatments, particularly newer and more costly medications. This financial constraint might limit access to the most effective treatments, leading to reliance on less effective or more affordable over-the-counter options, which might not fully address their needs. [3] Additionally, costs associated with healthcare visits, transportation, and the need for specialised care could present further challenges, especially for those with limited incomes. [3]

Geographic location can also affect access to constipation management. Patients living in rural or remote areas might have fewer options for specialist palliative care services and may need to travel long distances to receive care, which could delay treatment and result in prolonged discomfort. [10] In these regions, healthcare providers might have less experience or access to resources for managing complex cases of constipation, which could impact the quality of care. [3]

To address these challenges, expanding access to telemedicine and mobile health services could help provide remote consultations and follow-up care, potentially reducing the need for travel. [10] Additionally, supporting ongoing training for healthcare providers in rural and remote areas might help improve the management of constipation in palliative care settings. [3]


Care context

Patients with cancer often experience constipation due to a combination of factors, including opioid use for pain management, the effects of cancer itself on the gastrointestinal tract, and side effects from chemotherapy or radiation therapy. [4,8] The management of constipation in these patients typically involves a proactive approach, with regular assessment and the early initiation of both pharmacological and non-pharmacological interventions. Additionally, healthcare providers may need to adjust treatment plans frequently based on the patient's evolving condition, ensuring that constipation is managed effectively alongside their cancer treatment. [3,8]

Managing constipation in paediatric palliative care presents unique challenges due to the differences in anatomy, physiology, and developmental stages compared to adults. Children may experience constipation as a result of their underlying illness, medications, or reduced physical activity, and the condition can significantly impact their quality of life. [4] In paediatric settings, a combination of dietary modifications, such as increasing fibre and fluid intake, and the use of gentle laxatives is commonly recommended. However, the choice of laxative and dosage must be carefully considered to avoid adverse effects, particularly in younger children. [6] Additionally, non-pharmacological approaches, such as encouraging physical activity and establishing regular toileting routines, are important components of managing constipation in paediatric patients. [3]

In aged care settings, constipation is a prevalent issue due to factors such as reduced mobility, poor dietary intake, and the frequent use of medications, including opioids, which can exacerbate constipation. [3] Managing constipation in older adults often requires a tailored approach, with regular assessment and a combination of pharmacological and non-pharmacological interventions. Dietary adjustments, such as increasing fibre and fluid intake, are commonly recommended but must be monitored carefully due to the risk of dehydration and other complications in older adults. [6]

For patients with non-cancer conditions like heart failure or COPD, constipation management may require adjustments to standard protocols. For example, fluid restrictions common in heart failure patients complicate the use of fibre-based interventions, requiring alternative strategies like stool softeners or osmotic laxatives. [4] Similarly, patients with COPD who experience reduced mobility may benefit from targeted physical activities that can be integrated into their overall care plan. [6]

Implications for families and carers

The management of constipation in palliative care can have broad implications for families and carers, who are often deeply involved in the patient’s care. Carers may experience anxiety and stress, especially when they feel unable to alleviate the patient’s discomfort. This emotional burden can be compounded when carers do not receive enough information or support from healthcare professionals, leading to feelings of frustration and emotional exhaustion. [6] The ongoing need to monitor and manage the patient’s symptoms can create a continuous sense of vigilance and concern, adding to the overall stress. [6]

The physical demands on carers can be considerable. Managing constipation often involves administering medications, making dietary adjustments, and sometimes assisting with toileting, which can be physically taxing—particularly for elderly carers or those with their own health issues. [4] The continuous involvement required in the patient’s care can lead to physical fatigue, further adding to the burden of caregiving. [4]

Effective management of constipation in palliative care may depend on carers being well-informed and supported. Carers benefit from clear instructions and education on administering treatments, monitoring symptoms, and knowing when to seek medical help, which can help reduce the stress and uncertainty they often face. [3] Additionally, it is helpful for healthcare providers to ensure that carers have access to support services, such as respite care and professional advice, to assist them in managing their responsibilities without becoming overwhelmed. [6]

Carers often play a role in decision-making about the patient’s care, which can be challenging if they feel unprepared or unsupported. Clear and open communication with healthcare providers can help carers feel more confident in their decisions and ensure that their perspectives are considered in the care process. [6] Involving carers in decision-making may also reduce feelings of isolation and ensure that the patient’s care plan aligns with their wishes and needs. [6]

  1. Dzierżanowski T, Larkin P. Proposed criteria for constipation in palliative care patients. A multicenter cohort study. J Clin Med. 2020;10(1):40.
  2. Shimizu M, Maeda I, Kessoku T, Ishiki H, Matsuura T, Hiratsuka Y, et al. The safety and effectiveness of naldemedine for opioid-induced constipation in patients with advanced cancer in real-world palliative care settings: A multicenter prospective observational study. Support Care Cancer. 2024;32(8):504.
  3. McIlfatrick S, Muldrew DHL, Beck E, Carduff E, Clarke M, Finucane A, et al. Examining constipation assessment and management of patients with advanced cancer receiving specialist palliative care: A multi-site retrospective case note review of clinical practice. BMC Palliat Care. 2019;18(1):57.
  4. Candy B, Jones L, Larkin PJ, Vickerstaff V, Tookman A, Stone P. Laxatives for the management of constipation in people receiving palliative care. Cochrane Database Syst Rev. 2015;2015(5):CD003448.
  5. Davies A, Leach C, Caponero R, Dickman A, Fuchs D, Paice J, et al. MASCC recommendations on the management of constipation in patients with advanced cancer. Support Care Cancer. 2020;28(1):23-33.
  6. Hasson F, Muldrew D, Carduff E, Finucane A, Graham-Wisener L, Larkin P, et al. 'Take more laxatives was their answer to everything': A qualitative exploration of the patient, carer and healthcare professional experience of constipation in specialist palliative care. Palliat Med. 2020;34(8):1057-1066.
  7. Biçak Ayik DP, Can GP. Effect of auricular acupressure in management of constipation in palliative care patients. J Palliat Care. 2023:8258597231181040.
  8. Candy B, Jones L, Vickerstaff V, Larkin PJ, Stone P, Candy B. Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with cancer and people receiving palliative care. Cochrane Database Syst Rev. 2018;2018(6):CD006332.
  9. Burke C, Doody O, Lloyd B. Healthcare practitioners' perspectives of providing palliative care to patients from culturally diverse backgrounds: A qualitative systematic review. BMC Palliat Care. 2023;22(1):182.
  10. Sánchez-Cárdenas MA, Iriarte-Aristizábal MF, León-Delgado MX, Rodríguez-Campos LF, Correa-Morales JE, Cañón-Piñeros A, et al. Rural palliative care telemedicine for advanced cancer patients: A systematic review. Am J Hosp Palliat Care. 2023 Aug;40(8):936-944.

Last updated 05 December 2024